Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study

Figure 5

Overall survival of the 68 elderly patients with advanced NSCLC who received PD-1 blockade monotherapy.